Fresenius Health Partners

What Fresenius Health Partners does

Fresenius Medical Care (legally Fresenius Medical Care AG & Co. KGaA) is a publicly listed, vertically integrated kidney care company headquartered in Bad Homburg, Germany, operating as a subsidiary of Fresenius SE & Co. KGaA. The company delivers the full dialysis value chain — from proprietary dialysis machines (5008X CAREsystem, 2008T BlueStar), water treatment systems (AquaA, AquaBPlus, AquaB LITE, AquaC UNO H), disposables (dialyzers, concentrates, bloodlines), and renal pharmaceuticals (Venofer, Velphoro), to home dialysis devices (Liberty Select Cycler, stay.safe CAPD, kinexus), critical care systems (Novalung ECMO), and fluid management tools (CLiC Device, Crit-Line IV Monitor). Clinical operations are delivered through approximately 3,600 Fresenius Kidney Care Clinics in 40 countries, supported by roughly 110,000 employees and 35 production sites in 19 countries, with 44 million dialysis treatments performed in 2025.

The business generates revenue across three streams: recurring dialysis services delivered through company-owned clinics, hardware and disposable sales to dialysis providers and hospitals, and pharmaceutical sales for renal patients. Services extend beyond core dialysis to include vascular access care, laboratory and diagnostic services, renal pharmacy, physician practice management (Fresenius Physician Solutions), and renal research (Renal Research Institute, Frenova), plus apheresis services. GTM is enterprise field sales plus direct-to-patient delivery: healthcare professionals and nephrologists are targeted through a dedicated Doctors Corner portal and physician solutions division, while patients access care via admissions processes and a Find a Center locator.

The primary customer segment is patients with chronic kidney disease and end-stage renal disease requiring ongoing in-center hemodialysis, home hemodialysis, or peritoneal dialysis; a secondary segment is healthcare professionals (nephrologists, dialysis nurses, hospital providers). Pricing is not publicly disclosed and is determined by patient needs, insurance coverage, and provider arrangements. The company was established as a separate listed entity in 1996 and trades on the Frankfurt Stock Exchange under ticker FME.

Name

Fresenius Health Partners

Legal name

Fresenius Medical Care AG & Co. KGaA

Website

https://fmcna.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Fresenius Medical Care is a publicly listed, vertically integrated dialysis company operating approximately 3,600 kidney care clinics across 40 countries, manufacturing proprietary dialysis machines, disposables, and renal pharmaceuticals, and serving patients with chronic and end-stage kidney disease alongside nephrologists and healthcare providers.

Ownership category

akta.pro rank

NAICS

Kidney Dialysis Centers (621492), Ambulatory Health Care Services (621), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Home Health Care Services (8082), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Outpatient Dialysis & Kidney Care Centers (HLAFABAE)

akta.pro secondary industries

Dialysis Services (Hemodialysis & Peritoneal Dialysis) (HLAKAHAC), Hemodialysis Machines & Systems (HLAHAKAA), Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)

Keywords

• Dialysis services
• Kidney care
• Renal pharmaceuticals
• Dialysis equipment
• Home dialysis

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Dialysis Services: Direct patient care services through company-owned dialysis centers providing in-center hemodialysis, home hemodialysis, and peritoneal dialysis treatments. Revenue generated from dialysis treatment sessions and related clinical care services.
2. Medical Products and Equipment: Sale of dialysis machines, dialyzers, bloodlines, concentrates, water treatment systems, and related disposables to dialysis providers and healthcare facilities.
3. Renal Pharmaceuticals: Sale of prescription renal drugs including Venofer and Velphoro for managing conditions in dialysis patients.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

Fresenius Health Partners operates as a vertically integrated renal care company that manufactures and sells dialysis machines, water treatment systems, dialyzers, bloodlines, renal pharmaceuticals (Venofer, Velphoro), and related medical devices, while also delivering in-center hemodialysis, home hemodialysis, peritoneal dialysis, vascular access care, renal pharmacy, and laboratory services. Patient care is delivered through approximately 3,600 owned dialysis centers across 40 countries, supported by 35 production sites in 19 countries and around 110,000 employees worldwide.

Product overview

Fresenius Medical Care operates as a vertically integrated company offering products and services for the entire dialysis value chain. The comprehensive portfolio includes: In-center dialysis equipment (5008X CAREsystem, 2008T BlueStar dialysis machines, water treatment systems like AquaA/AquaBPlus/AquaB LITE); Home dialysis solutions (Liberty Select Cycler, stay•safe CAPD system, kinexus for peritoneal dialysis, home hemodialysis products); Critical care therapy (Novalung ECMO therapy for heart and lung support); Fluid management devices (CLiC Device, Crit-Line IV Monitor); Renal pharmaceuticals (Venofer, Velphoro); and clinical services (kidney care clinics, vascular access care, laboratory services, renal pharmacy, practice management under Fresenius Physician Solutions, and renal research through Renal Research Institute and Frenova). The company delivers care through approximately 3,600 dialysis centers in 40 countries, supported by manufacturing at 35 production sites in 19 countries.

Differentiator

Problem solved

Functional benefit

Brands

• HighVolumeHDF: Hemodiafiltration therapy for in-center patients
• 5008X CAREsystem
• Liberty Select Cycler
• stay·safe
• kinexus
• Novalung
• CLiC Device
• Crit-Line IV Monitor
• Venofer
• Velphoro

Quantifiable outcome

• More than 44 million dialysis treatments delivered in 2025
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Innovative Renal Care: Innovative Renal Care (formerly American Renal Associates) operates dialysis clinics across the United States. Directly competes with Fresenius Kidney Care in US in-center and home dialysis markets.
• DaVita: DaVita is the other dominant global dialysis clinic operator and Fresenius Medical Care's primary US duopoly competitor. Operates thousands of dialysis centers, provides in-center hemodialysis, home dialysis, and related renal care services, with overlapping product and service offerings.
• Diaverum: Diaverum is a global dialysis services provider operating hundreds of clinics across Europe, Latin America, the Middle East, and Asia. Directly comparable as a multinational dialysis clinic operator competing with Fresenius Kidney Care in international markets.
• U.S. Renal Care: U.S. Renal Care operates a network of outpatient dialysis clinics across multiple US states. Directly comparable as a US-focused dialysis clinic operator competing with Fresenius Kidney Care for patients and nephrologist partnerships.

Emerging players

• Outset Medical: Outset Medical produces the Tablo Hemodialysis System, a compact device designed for in-center, home, and acute care settings. Targets the same home dialysis and portable dialysis growth vector that Fresenius is pursuing with Liberty Select Cycler and home hemodialysis products.

Broad incumbents

• Baxter International: Baxter manufactures peritoneal dialysis systems (e.g., HomeChoice, Amia) and dialyzer-related products, competing with Fresenius's PD and disposable product lines. Also serves broader acute and chronic renal care, making it a broad incumbent in the renal devices space.
• B. Braun Avitum: B. Braun Avitum is the renal care division of B. Braun, manufacturing dialysis machines, dialyzers, bloodlines, and operating dialysis centers in Europe and select international markets. Overlaps with Fresenius across both products and clinic operations.
• Nipro Medical Corporation: Nipro manufactures dialyzers, dialysis machines, bloodlines, and related disposables globally, with strong presence in Japan and emerging markets. Competes with Fresenius in the medical products segment of the dialysis value chain.
• Asahi Kasei Medical: Asahi Kasei Medical is a leading global manufacturer of dialyzers (membrane filters) and other renal care products. Competes with Fresenius in the dialyzers segment and supplies many dialysis providers worldwide.

Regional players

• Satellite Healthcare: Satellite Healthcare is a US non-profit dialysis provider operating centers primarily in California, Texas, and select other states. Operates in the same dialysis care delivery category as Fresenius Kidney Care but with a narrower regional footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/FME_Global
• YouTubeyoutube.com/c/FreseniusMedicalCareNorthAmerica
• Facebookfacebook.com/FreseniusMedicalCareNA
• LinkedInlinkedin.com/company/fresenius-medical-care

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fresenius Health Partners